Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Biotech IncfiledCriticalJanssen Biotech Inc
Priority to ARP200100070ApriorityCriticalpatent/AR117798A1/en
Publication of AR117798A1publicationCriticalpatent/AR117798A1/en
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents
(AREA)
Micro-Organisms Or Cultivation Processes Thereof
(AREA)
Peptides Or Proteins
(AREA)
Abstract
La descripción se relaciona con neoantígenos prostáticos, polinucleótidos que los codifican, vectores, células huésped, partículas de virus recombinantes, vacunas que comprenden los neoantígenos, moléculas proteináceas que se unen a los neoantígenos prostáticos, y métodos para elaborarlos y usarlos.The description relates to prostate neoantigens, polynucleotides that encode them, vectors, host cells, recombinant virus particles, vaccines that comprise the neoantigens, proteinaceous molecules that bind to prostate neoantigens, and methods for making and using them.
ARP200100070A2020-01-102020-01-10
NEOANTIGENS PROSTATICS AND THEIR USES
AR117798A1
(en)